108TH CONGRESS
2D SESSION
H. R. 5213
AN ACT
To expand research information regarding multi-
disciplinary research projects and epidemiological
studies.
108TH CONGRESS
2D SESSION
H. R. 5213
AN ACT
To expand research information regarding multidisciplinary
research projects and epidemiological studies.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ‘‘Research Review Act
of 2004’’.
SEC. 2. MULTI-DISCIPLINARY RESEARCH TEAM AND CON-
SORTIA REPORT.
(a) IN GENERAL.—The Secretary of Health and
Human Services (referred to in this Act as the ‘‘Sec-
retary’’), in coordination with the Director of the National
Institutes of Health, shall prepare a report outlining the
methods by which the Roadmap for Medical Research, an
initiative of such Institutes, has advanced the use of multi-
disciplinary research teams and consortia of research in-
stitutions to advance treatments, develop new therapies,
and collaborate on clinical trials, including with respect
to spinal cord injury and paralysis research.
(b) REPORT.—Not later than February 1, 2005, the
Secretary shall submit the report under subsection (a) to
the Committee on Energy and Commerce of the House
of Representatives and to the Committee on Health, Edu-
cation, Labor, and Pensions of the Senate.
SEC. 3. EPIDEMIOLOGICAL STUDY REPORT.
(a) IN GENERAL.—The Secretary, acting through the
Director of the Centers for Disease Control and Preven-
tion, shall prepare a report outlining the epidemiological
studies currently under way at such Centers, future
planned studies, the criteria involved in determining what
epidemiological studies to conduct, defer, or suspend, and
the scope of those studies, including with respect to the
inflammatory bowel disease epidemiological study. The re-
port shall include a description of the activities the Cen-
ters for Disease Control and Prevention undertakes to es-
tablish partnerships with research and patient advocacy
communities to expand epidemiological studies.
(b) REPORT.—Not later than May 1, 2005, the Sec-
retary shall submit the report under subsection (a) to the
Committee on Energy and Commerce of the House of
Representatives and to the Committee on Health, Edu-
cation, Labor, and Pensions of the Senate.
SEC. 4. STUDY BY GOVERNMENT ACCOUNTABILITY OFFICE
ON MEDICARE AND MEDICAID COVERAGE
STANDARDS.
(a) IN GENERAL.—The Comptroller General of the
United States shall conduct a study on the coverage stand-
ards that, under the programs under titles XVIII and XIX
of the Social Security Act (commonly known as Medicare
and Medicaid, respectively), apply to patients with inflam-
matory bowel disease for the following therapies:
(1) Parenteral nutrition.
(2) Enteral nutrition formula.
(3) Medically necessary food products.
(4) Ostomy supplies.
(5) Therapies approved by the Food and Drug
Administration for Crohn’s disease and ulcerative
colitis.
(b) CONTENT.—The study under subsection (a) shall
take into account the appropriate outpatient or home
health care delivery settings.
(c) REPORT.—Not later than six months after the
date of the enactment of this Act, the Comptroller General
shall submit to the Congress a report describing the find-
ings of the study under subsection (a).
SEC. 5. STUDY BY GOVERNMENT ACCOUNTABILITY OFFICE
INVOLVING DISABILITY INSURANCE.
(a) IN GENERAL.—The Comptroller General of the
United States shall conduct a study of the problems pa-
tients encounter when applying for disability insurance
benefits under title II of the Social Security Act. The
study shall include recommendations for improving the ap-
plication process for patients with inflammatory bowel dis-
ease.
(b) REPORT.—Not later than six months after the
date of the enactment of this Act, the Comptroller General
shall submit to the Congress a report describing the find-
ings of the study under subsection (a).
Passed the House of Representatives October 7,
2004.
Attest:
Clerk.